Health care cost associated with acute and stable asthma: an economic analysis Source: Eur Respir J 2003; 22: Suppl. 45, 418s Year: 2003
Cost analysis for patients with severe asthma receiving omalizumab treatment Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019
Health care costs associated with acute asthma: a economic analysis Source: Eur Respir J 2002; 20: Suppl. 38, 42s Year: 2002
The cost analysis of our COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006
Health care claims analysis to quantify the burden of moderate-to-severe asthma Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012
A 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use Source: Eur Respir J 2016; 48: 726-733 Year: 2016
A highly complex home care service for COPD in LTOT may reduce the exacerbations and the hospitalizations Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011
Dispensed asthma therapy and medical resource utilisation in asthma patients: results from the L777 observational study Source: Annual Congress 2009 - Epidemiology of asthma Year: 2009
Antibiotics prescriptions increased medical costs for COPD exacerbations. Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019
An outreaching model of tertiary difficult asthma care reduces adverse asthma outcomes and healthcare utilisation costs Source: Eur Respir J 2016; 47:1857-1860 Year: 2016
Cost of health care associated with workplace exacerbation of asthma Source: Eur Respir J 2007; 30: Suppl. 51, 157s Year: 2007
Persistent asthma: disease control, resource utilisation and direct costs Source: Eur Respir J 2002; 20: 260-267 Year: 2002
Reduced cost of unscheduled healthcare resource use in patients with well controlled asthma Source: Eur Respir J 2005; 26: Suppl. 49, 44s Year: 2005
Difference in healthcare resource use among children with asthma who did and did not have allergic rhinitis diagnosis in a UK primary care database Source: Eur Respir J 2002; 20: Suppl. 38, 332s Year: 2002
Provision of self-management plans for treatment of COPD exacerbations reduce hospital admissions Source: Eur Respir J 2007; 30: Suppl. 51, 569s Year: 2007
Analysis of causes and quality of patients‘ treatment with often severe asthma exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 72s Year: 2007
Combination asthma medication and healthcare use in severe or difficult-to-treat asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004
Symptom pattern and treatment for people non-compliant with asthma medication Source: Annual Congress 2005 - Allergic rhinitis and asthma in primary care Year: 2005
Does long-term macrolide treatment reduce asthma exacerbations? An individual patient data meta-analysis Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019
Cost analysis of FeNO for asthma diagnosis in primary care in Germany. Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs Year: 2018